Literature DB >> 15234275

Dietary influences on endocrine-inflammatory interactions in prostate cancer development.

Emily Ho1, Thomas W-M Boileau, Tammy M Bray.   

Abstract

Prostate cancer is the most frequently diagnosed non-cutaneous cancer and is the second leading cause of cancer death in American men. The focus of this review is to define the relationship between hormonal (testosterone/estrogens) stimulation of chronic inflammation, generation of reactive oxygen species (ROS), and uncontrolled prostate cell proliferation, and review putative dietary chemoprevention strategies that focus on these processes. It has been proposed that elevated estrogen in men who already have high blood testosterone are at high risk for prostate cancer. We hypothesized that elevated estrogen, in the presence of testosterone, causes prolonged activation of a redox-sensitive transcription factor, nuclear factor kappa B (NF kappa B), that initiates and amplifies an inflammatory cascade within the prostate and results in sustained oxidative and nitrative damage. The inflammatory cascade is proposed to link with uncontrolled proliferation through up-regulated Wnt signal and abnormal catenin accumulation in the prostate. Finally, a strategy that emphasizes a "whole food" based approach to cancer prevention by selecting food products that bear anti-inflammatory and anti-proliferative properties may be most promising as an effective dietary chemopreventive strategy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234275     DOI: 10.1016/j.abb.2004.01.009

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling.

Authors:  Mohammad Saleem; Imtiyaz Murtaza; Rohinton S Tarapore; Yewseok Suh; Vaqar Mustafa Adhami; Jeremy James Johnson; Imtiaz Ahmad Siddiqui; Naghma Khan; Mohammad Asim; Bilal Bin Hafeez; Mohammed Talha Shekhani; Benyi Li; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2009-02-20       Impact factor: 4.944

2.  Joint effects of inflammation and androgen metabolism on prostate cancer severity.

Authors:  Timothy R Rebbeck; Hanna Rennert; Amy H Walker; Saarene Panossian; Teo Tran; Kyle Walker; Elaine Spangler; Margerie Patacsil-Coomes; Rajeev Sachdeva; Alan J Wein; S Bruce Malkowicz; Charnita Zeigler-Johnson
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

Review 3.  Oxidative stress in prostate cancer.

Authors:  Lakshmipathi Khandrika; Binod Kumar; Sweaty Koul; Paul Maroni; Hari K Koul
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

4.  TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.

Authors:  Bilge Debelec-Butuner; Cansu Alapinar; Nursah Ertunc; Ceren Gonen-Korkmaz; Kutsal Yörükoğlu; Kemal Sami Korkmaz
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

5.  Phase II prospective randomized trial of weight loss prior to radical prostatectomy.

Authors:  Susanne M Henning; Colette Galet; Kiran Gollapudi; Joshua B Byrd; Pei Liang; Zhaoping Li; Tristan Grogan; David Elashoff; Clara E Magyar; Jonathan Said; Pinchas Cohen; William J Aronson
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-12-04       Impact factor: 5.554

6.  Modulatory effects of Crataeva nurvala bark against testosterone and N-methyl-N-nitrosourea-induced oxidative damage in prostate of male albino rats.

Authors:  Dugganaboyana Guru Kumar; Purandekkattil Deepa; Muthaiyan A Rathi; Periasamy Meenakshi; Velliyur K Gopalakrishnan
Journal:  Pharmacogn Mag       Date:  2012-10       Impact factor: 1.085

7.  Evaluation of antioxidant activity of three common potato (Solanum tuberosum) cultivars in Iran.

Authors:  Faride Hesam; Gholam Reza Balali; Reza Taheri Tehrani
Journal:  Avicenna J Phytomed       Date:  2012
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.